Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study

Human Immunology

Volumn 72, Issue 5, 2011, Pages 426-430

  Baker, Allison R ^a   Zalwango, Sarah ^b   Malone, LaShaunda L ^a   Igo, Robert P ^a   Qiu, Feiyou ^a   Nsereko, Mary ^b   Adams, Mark D ^a   Supelak, Pamela ^a   Mayanja Kizza, Harriet ^b,c   Boom, W Henry ^a,b   Stein, Catherine M ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

Author keywords

Family study; Fine map; Immunogenetics; Infectious disease; TB genetics

Indexed keywords

CATHEPSIN X; INTERLEUKIN 6; MELANOCORTIN 3 RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CARD11 GENE; CHILD; CHROMOSOME 20; CHROMOSOME 7P; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GENOME; HAPLOTYPE; HOUSEHOLD; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS; UGANDA;

ADOLESCENT; ADULT; AGED; CARD SIGNALING ADAPTOR PROTEINS; CATHEPSIN Z; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GUANYLATE CYCLASE; HAPLOTYPES; HUMANS; INFANT; INTERLEUKIN-6; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, MELANOCORTIN, TYPE 3; TUBERCULOSIS, PULMONARY; UGANDA;

EID: 79954613602     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.02.016     Document Type: Article

References (49)

1. Global Tuberculosis Control: Epidemiology, Strategy, Financing: WHO Report 2009 2009, World Health Organization, World Health Organization, Geneva.
2. Murray C.J., Styblo K., Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990, 65:6-24.
3. Comstock G. Epidemiology of tuberculosis. Am Rev Respir Dis 1982, 125:8-15.
4. Skamene E., Schurr E., Gros P. Infection genomics: Nramp1 as a major determinant of natural resistance to intracellular infections. Annu Rev Med 1998, 49:275-287.
5. Kramnik I., Dietrick W., Demant P., Bloom B. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2000, 97:8560-8565.
6. Kallmann F., Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc 1943, 47:549-574.
7. Simonds B. Tuberculosis in Twins 1963, Pitman Medical, London.
8. Comstock G. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978, 117:621-624.
9. Shaw M.A., Collins A., Peacock C.S., Miller E.N., Black G.F., Sibthorpe D., et al. Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFa. Tuber Lung Dis 1997, 78:35-45.
10. Moller M., de Wit E., Hoal E.G. Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol Med Microbiol 2010, 58:3-26.
11. Bellamy R., Beyers N., McAdam K., Ruwende C., Gie R., Samaai P., et al. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci USA 2000, 97:8005-8009.
12. Greenwood C., Fujiwara T., Boothroyd L., Miller M., Frappier E., Fanning E., et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 2000, 67:405-416.
13. Jamieson S., Miller E., Black G., Peacock C., Cordell H., Howson J., et al. Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun 2004, 5:46-57.
14. Miller E., Jamieson S., Joberty C., Fakiola M., Hudson D., Peacock C., et al. Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians. Genes Immun 2004, 5:63-67.
15. Stein C.M., Zalwango S., Chiunda A.B., Millard C., Leontiev D.V., Horvath A.L., et al. Linkage and association analysis of candidate genes for TB and TNFalpha cytokine expression: evidence for association with IFNGR1, IL-10, and TNF receptor 1 genes. Hum Genet 2007, 121:663-673.
16. Stein C.M., Zalwango S., Malone L.L., Won S., Mayanja-Kizza H., Mugerwa R.D., et al. Genome scan of M. tuberculosis infection and disease in Ugandans. PLoS ONE 2008, 3:e4094.
17. van Crevel R., Ottenhoff T., van der Meek J. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002, 15:294-309.
18. Ladel C.H., Blum C., Dreher A., Reifenberg K., Kopf M., Kaufmann S.H. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 1997, 65:4843-4849.
19. Oral H.B., Budak F., Uzaslan E.K., Basturk B., Bekar A., Akalin H., et al. Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. Cytokines 2006, 35:143-147.
20. Berrington W.R., Hawn T.R. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?. Immunol Rev 2007, 219:167-186.
21. Cooke G.S., Campbell S.J., Bennett S., Lienhardt C., McAdam K.P., Sow O., et al. Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. Am J Respir Crit Care Med 2008, 178:203-207.
22. Pruitt K.D., Tatusova T., Maglott D.R. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 2007, 35:D61-D65.
23. Guwattude D., Nakakeeto M., Jones-Lopez E., Maganda A., Chiunda A., Mugerwa R., et al. Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol 2003, 158:887-898.
24. Stein C.M., Nshuti L., Chiunda A.B., Boom W.H., Elston R.C., Mugerwa R.D., et al. Evidence for a major gene influence on tumor necrosis factor-alpha expression in tuberculosis: path and segregation analysis. Hum Hered 2005, 60:109-118.
25. Diagnostic standards and classification of tuberculosis in adults and children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000, 161:1376-1395. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.
26. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999: This is a joint statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). Am J Respir Crit Care Med 2000, 161:S221-S247. This statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999.
27. Edwards B.J., Haynes C., Levenstien M.A., Finch S.J., Gordon D. Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies. BMC Genet 2005, 6:18.
28. Gray-McGuire C., Bochud M., Goodloe R., Elston R.C. Genetic association tests: a method for the joint analysis of family and case-control data. Hum Genomics 2009, 4:2-20.
29. Stein C.M. Genetic epidemiology of tuberculosis susceptibility: IMPACT of study design. PLoS Pathog 2011, 7:e1001189.
30. The International HapMap Project. Nature 2003, 426:789-796. International HapMap Consortium.
31. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861. International HapMap Consortium.
32. Mangin B., Goffinet B., Rebai A. Constructing confidence intervals for QTL location. Genetics 1994, 138:1301-1308.
33. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
34. Lewinsohn D.A., Zalwango S., Stein C.M., Mayanja-Kizza H., Okwera A., Boom W.H., et al. Whole blood interferon-gamma responses to Mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda. PLoS ONE 2008, 3:e3407.
35. Velez D.R., Wejse C., Stryjewski M.E., Abbate E., Hulme W.F., Myers J.L., et al. Variants in Toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans. Hum Genet 2010, 127:65-73.
36. Velez D.R., Hulme W.F., Myers J.L., Stryjewski M.E., Abbate E., Estevan R., et al. Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians. Int J Tuberc Lung Dis 2009, 13:1068-1076.
37. Velez D.R., Hulme W.F., Myers J.L., Weinberg J.B., Levesque M.C., Stryjewski M.E., et al. NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet 2009, 126:643-653.
38. Iafrate A.J., Feuk L., Rivera M.N., Listewnik M.L., Donahoe P.K., Qi Y., et al. Detection of large-scale variation in the human genome. Nat Genet 2004, 36:949-951.
39. Wang K., Li M., Hadley D., Liu R., Glessner J., Grant S.F., et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 2007, 17:1665-1674.
40. Bodmer W., Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008, 40:695-701.
41. Ardlie K.G., Kruglyak L., Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 2002, 3:299-309.
42. Chanock S.J., Manolio T., Boehnke M., Boerwinkle E., Hunter D.J., Thomas G., et al. Replicating genotype-phenotype associations. Nature 2007, 447:655-660.
43. Baker A, Randhawa A, Shey M, de Kock M, Kaplan G, Adams M, et al. Comparison of genotype frequencies in Toll-like receptor genes in Ugandans, South Africans, and African HapMap populations. Presented at the American Society of Human Genetics annual meeting, Honolulu, HI, 22 October 2009.
44. Nicolae D.L., Gamazon E., Zhang W., Duan S., Dolan M.E., Cox N.J. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 2010, 6;:e1000888.
45. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367.
46. Thye T., Vannberg F.O., Wong S.H., Owusu-Dabo E., Osei I., Gyapong J., et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 2010, 42:739-741.
47. Gonzalez E., Kulkarni H., Bolivar H., Mangano A., Sanchez R., Catano G., et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005, 307:1434-1440.
48. McCarroll S.A., Altshuler D.M. Copy-number variation and association studies of human disease. Nat Genet 2007, 39:S37-S42.
49. Adams L.A., Moller M., Nebel A., Schreiber S., van der Merwe L., van Helden P.D., Hoal E.G. Polymorphisms in MC3R promoter and CTSZ 3'UTR are associated with tuberculosis susceptibility. Eur J Hum Genet 2011, 10.1038/ejhg2011.1.